Related Experiment Videos
Peritonectomy procedures.
1Program in Peritoneal Surface Malignancy, Washington Cancer Institute, 100 Irving St., NW, Suite CG-185, Washington, DC 20010, USA. Paul.Sugarbaker@medstar.net
Surgical Oncology Clinics of North America
|October 22, 2003
Summary
Effective treatment for peritoneal surface malignancy involves surgical peritonectomy procedures combined with intraperitoneal chemotherapy. Careful patient selection and complete cytoreduction are crucial for long-term survival in these complex cases.
Area of Science:
- Surgical oncology
- Gastrointestinal oncology
Background:
- Peritoneal surface malignancy presents a complex treatment challenge.
- A combined modality approach is necessary for effective management.
Purpose of the Study:
- To illustrate visceral and parietal peritonectomy procedures for peritoneal surface malignancy.
- To emphasize the importance of complete cytoreduction and patient selection.
Main Methods:
- Detailed description of visceral and parietal peritonectomy techniques.
- Discussion of patient selection criteria for combined modality treatment.
- Highlighting the necessity of complete resection of visible disease.
Main Results:
- Complete cytoreduction is achievable through specific peritonectomy procedures.
- The surgical approach requires extensive operative time (8-12 hours).
- Procedure selection is dictated by malignancy distribution and extent.
Conclusions:
- Peritonectomy procedures combined with perioperative intraperitoneal chemotherapy offer a viable treatment strategy.
- Meticulous surgical technique and patient selection are paramount for successful outcomes.
- Achieving complete cytoreduction is essential for long-term survival in peritoneal surface malignancy.